Editorial Board Members from Pharmaceuticals Featured in the 2023 Highly Cited Researchers List Published by Clarivate

Recently, Clarivate™ revealed its 2023 list of Highly Cited Researchers™—individuals at universities, research institutes, and commercial organizations.

The scientists who were selected for this year’s list of Highly Cited Researchers published highly cited papers in the 11-year period from January 2012 to December 2022, with citation frequency in the top 1% of academic subjects and the same year of publication in the Web of Science™ database. This year, 7125 Highly Cited Researcher 2023 designations were issued to 6,849 individuals, representing just 1 in 1000 researchers worldwide. This means that these researchers have demonstrated an incredible level of significant and broad influence in their chosen field or fields over the last decade. The list is truly global, spanning 67 countries or regions and spread across a diverse range of research sciences and social sciences.

According to our statistics, 3 members of the Editorial Board of Pharmaceuticals (ISSN: 1424-8247) were selected for the list of Highly Cited Researchers by Clarivate™ in 2023. They are being recognized for their high-quality scientific research achievements and outstanding contributions to their professional fields. The Pharmaceuticals Editorial Office sincerely congratulates all elected editorial members and hopes that they continue to have an academically productive relationship with the journal.